Showing results (381-390 of 675) with videos related to
Sort By:
Pageof 68
Nature Medicine|July 26, 2011
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaTimothy Best, Dalin Li, Andrew D Skol, et al.Cancer Research|April 1, 2008
The signatures of autozygosity among patients with colorectal cancerManny D Bacolod, Gunter S Schemmann, Shuang Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate CancerKonrad H Stopsack, Joseph Vijai, Michael Conry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast CancerSteven J Isakoff, Erica L Mayer, Lei He, et al.JAMA Oncology|November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAKasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.Science Translational Medicine|October 5, 2022
A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fosYuan Liu, Neel Chudgar, Brooke Mastrogiacomo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2022
Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndromeYing L Liu, Karen A Cadoo, Anna Maio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control studyAndrea Eisen, Jan Lubinski, Jan Klijn, et al.Pageof 68